美銀證券:維持港交所(0388.HK)“買入”評級 目標價529港元
美銀證券發佈研究報吿稱,維持港交所(0388.HK)“買入”評級,目標價529港元。港交所將於10月27日發表第三季業績,預計其第三季純利28億港元,按季持平;日均成交額預計為1650億港元,同比增長17%,按季增長9%。
報吿稱,考慮到港股表現疲弱,該行預計季內投資收入會減少,並認為今次業績不會成為股價主要推動力,但港交所仍然具防禦性。
該行表示,將於10月18日推出的A股期貨產品是港交所第4季重要關注點,如果最初的成交量能達到每天4萬張,將會是非常理想的表現;但若少於2萬張,就會低於投資者預期,並可能在短期內導致股價壓力,但相信長遠而言,只要資金繼續流入A股市場,交易量將回升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.